biosimilars

Views & Analysis

Breaking policy and perceptual barriers: Biosimilars

Experts from Research Partnership analyse the company’s Therapy Watch data to identify how market access policy has impacted the adoption of biosimilars.

Views & Analysis

Deep Dive: Market Access - Breaking Barriers

In this issue of Deep Dive we look at the changing landscape for pharma market access and start to assess the impact of the COVID-19 pandemic.

News

Merck & Co spin off could start a trend in big pharma

Merck & Co’s strategy to spin off its older drugs and biosimilars into a new stand-alone business will be closely watched by other pharma companies considering the same move, analysts h

Views & Analysis

3 key trends shaping the immunology market

From an increase in sales of interleukin inhibitors to the prevalence of biosimilars, this decade has been an eventful one in the immunology industry.

Views & Analysis